Bristol Myers Squibb appoints Christopher Boerner, Ph.D., to Chair of the Board of Directors, effective April 1, 2024.
Bristol Myers Squibb announced that its Board of Directors has unanimously elected Christopher Boerner, Ph.D., to serve as Chair of the Board, effective April 1, 2024. He succeeds Giovanni Caforio, M.D., who will step down as Chair of the Board…